Successful use of argatroban as a heparin substitute during cardiopulmonary bypass: heparin-induced thrombocytopenia in a high-risk cardiac surgical patient

JefWhereas heparin is the most widely used intravenous anticoagulant in the US for the treatment of thromboembolic disease and is a seminal adjunct to many clinical procedures، نويسنده , , its use can cause serious adverse events. Heparin-induced thrombocytopenia (HI، نويسنده ,

606613